InfuSystem Holdings, Inc. ( INFU) - Key Metrics
INFU Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.83 | $0.16 | $0.34 | $0.42 |
| 2026Q1 | $1.67 | $0.05 | $0.05 | -$0.04 |
| 2025Q4 | $1.78 | $0.10 | $0.35 | $0.21 |
| 2025Q3 | $1.76 | $0.11 | $0.41 | $0.36 |
| 2025Q2 | $1.73 | $0.12 | $0.34 | $0.28 |
INFU Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 15.08 |
| 2026Q1 | 0% | 45.87 |
| 2025Q4 | 0% | 22.43 |
| 2025Q3 | 0% | 23.55 |
| 2025Q2 | 0% | 13.00 |
INFU Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 4.30% | 0% |
| 2026Q1 | -0.46% | 0% |
| 2025Q4 | 2.31% | 0% |
| 2025Q3 | 3.43% | 0% |
| 2025Q2 | 4.44% | 0% |
INFU
Price: $13.40
52 week price:
Earnings Per Share: 0.39 USD
P/E Ratio: 31.08
Exchange: ASE
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 13129
Market Capitalization: 272.3 million